Back to results
US 11,951,164 B2Granted
Systems and methods for the preparation of vaccines utilizing predictably inactivated pathogens
AssigneePerumala Holdings, LLC
InventorMadhavan Pisharodi
Life of this patent
Estimating the term…
Abstract
A method is described for producing a vaccine from a neutered pathogenic source. The neutered pathogenic source may be a SARS-COV-2 virus that is neutered with a defined dose of UV-C light. The neutered SARS-COV-2 viral vaccine is administered through an inhalation pump.
Claims13
A method for producing an immunogenic composition comprising:
- (a) neutering an intact pathogenic source, wherein neutering the pathogenic source involves:
- destroying the genetic material of the pathogenic source by varying a dosage and/or a wavelength of UV-C radiation such that the pathogenic source is unable to reproduce or cause infection while leaving intact at least some or all of its membrane or structural proteins as antigens;
- and
- (b) aliquoting the neutered pathogenic source into containers,
- wherein the pathogenic source is neutered in a disinfectant unit comprising:
- a housing that is opaque to UV-C radiation/light;
- and
- a chamber enclosed within the housing, wherein the chamber comprises:
- (i) a chamber wall that is transparent to UV-C light;
- (ii) a chamber inlet;
- (iii) a chamber outlet;
- (iv) a centralized inner bore having an interior chamber surface facing the inner bore;
- (v) one or more UV-C light source positioned adjacent the interior surface;
- and
- (vi) a helical air flow diverter centralized within the inner bore proximal the one or more UV-C light sources, wherein the helical air flow diverter comprises one or more rungs, wherein the helical airflow diverter creates a centrifugal force and a helical path for the airflow pathway as the airflow pathway proceeds from the housing inlet to the housing outlet, and
- wherein varying the dosage and wavelength of the UV-C radiation involves:
- (A) controlling one or more of the following parameters:
- (i) intensity of UV-C emitted by the one or more UV-C light sources;
- (ii) number, type and position of the one or more UV-C light sources;
- and
- (iii) number of disinfectant units and/or number of chambers per disinfectant unit;
- and/or
- (B) controlling the exposure time of the pathogenic source to the UV-C by adjusting or varying one or more of the following parameters:
- (i) height of the chambers per disinfectant unit to thereby increase the height of the helical air flow diverter,
- (ii) number of helical rungs,
- (iii) a surface on the chamber wall with reflecting and/or irregular or crenulated walls to increase light ray reflections;
- (iv) speed of the air flow through the device,
- (v) a diameter of the helical rungs to control the proximity of the UV-C light source to the pathogens,
- (vi) air flow velocity through the disinfectant unit(s);
- and
- (vii) length of an air stream pathway through the disinfectant unit.
28 more elements
Dependencies are inferred from the claim text.